Navigation Links
Repligen Announces Completion of Patient Enrollment in Phase 2b Clinical Trial of RG2417 for Bipolar Depression
Date:9/30/2010

rapies are approved for the treatment of bipolar disorder, many individuals are unable to tolerate the treatment-related side effects, and incomplete clinical response, relapse and recurrence remain common clinical problems.  There are more than five million adults worldwide with bipolar disorder, an area of high unmet medical need due to the ineffectiveness and significant side effects of current therapies.

About Repligen Corporation

Repligen Corporation is a biopharmaceutical company focused on building an integrated company by developing and marketing innovative drugs that deliver the benefits of protein therapies in the fields of neurology and gastroenterology.  We have a core competency in large-scale protein manufacturing and have out-licensed certain biologics intellectual property, which provide ongoing sources of revenue.  Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453.  Additional information may be requested at www.repligen.com.

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical statements, including, without limitation, statements regarding future financial performance and position, management's strategy, plans and objectives for future operations, plans and objectives for product development, plans and objectives for present and future clinical trials and results of such trials, plans and objectives for regulatory approval, litigation, intellectual property protection, product development, manufacturing plans and performance, project
'/>"/>

SOURCE Repligen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Repligen to Present at the Rodman & Renshaw Annual Global Investment Conference
2. Repligen Announces Conference Call of First Quarter Fiscal Year 2011 Results
3. Repligen Reports Notice of Allowance of a United States Patent Covering the Use of Uridine to Treat the Symptoms of Bipolar Disorder
4. Repligen Receives Notice of Allowance for Recombinant Protein A Patent
5. Repligen Announces Long Term Supply Agreement with GE Healthcare for Recombinant Protein A
6. Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
7. Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
8. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
9. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
10. Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder
11. Warner Chilcott Announces the Closing of its $500 Million Senior Notes Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... PHILADELPHIA , Nov. 26, 2014  Cohen, ... on behalf of investors who purchased Nymox Pharmaceutical ... ) during the period from January 31, 2011 ... concerns whether Nymox and certain of its officers ... information in violation of Sections 10(b) and 20(a) ...
(Date:11/26/2014)... Nov. 26, 2014   Regulus Therapeutics Inc . ... the discovery and development of innovative medicines targeting microRNAs, ... President and CEO of Regulus, will present a company ... Healthcare Conference at the New York Palace Hotel on ... presentation will be webcast at the time of the ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge ... VVUS ), Horizon Pharma PLC (NASDAQ: ... and Johnson (NYSE: JNJ ), and Theravance Inc. ... companies can be accessed at: http://investor-edge.com/register . ... 4,758.25, up 0.07%, the Dow Jones Industrial Average edged 0.02% ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
... Jayex – http://www.jayex.com , the healthcare ... of Med-Extranet ; its online healthcare ... online access to educational videos, digital posters and public ... waiting room screens . Med-Extranet is ...
... FRANCISCO, Jan. 19, 2011 Jennerex, Inc. (San ... development of first-in-class, targeted oncolytic products for cancer, ... the newly-created position of vice president, regulatory affairs. ... regulatory strategies and managing all aspects of regulatory ...
Cached Medicine Technology:Digital Display System Specialist Jayex Launches Med-Extranet Online Media Library 2Digital Display System Specialist Jayex Launches Med-Extranet Online Media Library 3Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs 2
(Date:11/28/2014)... Miami's Plastic Surgery of the Face recently introduced ... Jeffrey Epstein is excited to offer patients the ... the site is uniquely designed for easing viewing on ... of all prospective rhinoplasty patients research upcoming procedures online. ... with smartphones, tablets, and laptops, as well as the ...
(Date:11/28/2014)... Minneapolis, Minnesota (PRWEB) November 28, 2014 ... one of the few insurance marketing organizations in ... the income and asset protection marketplace. Secura Consultants ... in partnership with Principal Financial Group, a leading ... with multiple ownership interests. With the ownership interest ...
(Date:11/28/2014)... THURSDAY, Nov. 27, 2014 (HealthDay News) -- Planning on ... from chronic heartburn -- clinically known as gastroesophageal reflux disease ... Dr. Jordan Josephson, an ear, nose and throat specialist ... these tips to help manage GERD on Thanksgiving: ... have at least two small meals throughout the day. It,s ...
(Date:11/28/2014)... November 28, 2014 PreDiabetes ... and treatment, helped employees learn their risk for ... blood screening at a local school in partnership ... Work initiative. , As the Presenting Sponsor ... , PreDiabetes Centers is co-hosting diabetes-prevention presentations at ...
(Date:11/28/2014)... 28, 2014 Mabel’s Labels , ... lose® and an award-winning company established by four moms, ... Esp, and Tricia Mumby have been honored with a ... with the PROFIT Award for Excellence in Entrepreneurship. , ... and Tricia Mumby) accepted the award on behalf of ...
Breaking Medicine News(10 mins):Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 3
... , , CHICAGO, ... Clinical Lab Expo in Chicago, Abbott (NYSE: ABT ) ... c4000(R) clinical chemistry analyzer which performs diagnostic tests that monitor general ... function. , , The new ...
... when employer-based coverage is not an option, survey finds, , ... United States who try to buy an individual health insurance ... because the premiums are just too expensive, according to a ... private foundation that supports independent research on health policy reform, ...
... ... serve residents, families , ... Wausau, Wisc. (Vocus) July 21, 2009 -- My InnerView, the leading provider of ... announced the creation of the My SeniorCare Edvantage Program, an online health management certificate ...
... , LAWRENCE, Mass. , July 21 ... leading manufacturer of innovative dialysis products, today announced that its ... distribution agreement with Fenwal, Inc. of Lake Zurich, Ill. ... medical technology company focused on improving blood collection, separation, safety ...
... Innovative child welfare practices from across the country offer hope ... , SEATTLE, July 21 All across America, child ... These changes are improving the lives of children in foster care as ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20070116/CASEYFAMILYLOGO ...
... , LA JOLLA, Calif., July 21 Kashi ... Dark Mocha Almond Chewy Granola Bar as the latest addition to the ... granola bar combines crunchy roasted almonds with rich dark chocolate and espresso for ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090331/LA91619LOGO ) , , "At Kashi, ...
Cached Medicine News:Health News:Abbott Launches New Instrument to Complete Family of ARCHITECT Immunochemistry Analyzers 2Health News:Abbott Launches New Instrument to Complete Family of ARCHITECT Immunochemistry Analyzers 3Health News:Abbott Launches New Instrument to Complete Family of ARCHITECT Immunochemistry Analyzers 4Health News:Millions in U.S. Can't Afford Health Insurance 2Health News:My InnerView and UW-Eau Claire Announce New Online Health Management Certificate Program for Senior Care Professionals 2Health News:My InnerView and UW-Eau Claire Announce New Online Health Management Certificate Program for Senior Care Professionals 3Health News:NxStage(R) Announces Extension of Medisystems Needle Supply and Distribution Agreement 2Health News:New Report Sets a Course for Improving Foster Care Systems 2Health News:New Report Sets a Course for Improving Foster Care Systems 3Health News:Kashi Company Introduces TLC(R) Dark Mocha Almond Chewy Bar 2
... The BiliChek measures total serum bilirubin ... no risk of infection compared to the ... Using light, BiliChek tests bilirubin levels without ... Only the replaceable plastic tip touches the ...
... 3900 Multi-Sample Osmometer is designed to ... to high volumes of samples. By ... technology for an accurate determination of ... throughput, the Advanced Instruments Model 3900 ...
... SSO typing technique utilises a generic PCR ... specific target region of an HLA locus. ... resulting amplicon to an array of Sequence ... membrane. The immobilisation of these probes is ...
... only a 20L sample size, which provides accurate ... convenience, the fully accessible probe design is easy ... only your most reliable option, it's the easiest ... a disposable sample tube, then place the tube ...
Medicine Products: